These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 35388593)
1. Prognostic value of tumor-stroma ratio in oral carcinoma: Role of cancer-associated fibroblasts. Qiu J; Jiang E; Shang Z Oral Dis; 2023 Jul; 29(5):1967-1978. PubMed ID: 35388593 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of tumor-stroma ratio in oral squamous cell carcinoma - A pilot study. Niranjan KC; Sarathy NA Ann Diagn Pathol; 2018 Aug; 35():56-61. PubMed ID: 29787931 [TBL] [Abstract][Full Text] [Related]
3. Multiperspective quantitative tumor-stroma ratio reveals histological areas associated with poor outcomes in oral squamous cell carcinoma. Wang S; Si Q; Wu Y; Sun Y; Zhang W; Huang X; Zeng T; Chen S; Yang X; Ni Y; Hu Q Cancer Med; 2023 Jun; 12(11):12161-12172. PubMed ID: 37184217 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological significance of tumor-stroma ratio in head and neck squamous cell carcinoma: A systematic review. Morais EF; Morais HG; Martins HD; Carlan LM; Costa AD; Freitas RD Med Oral Patol Oral Cir Bucal; 2022 Jul; 27(4):e301-e309. PubMed ID: 35717622 [TBL] [Abstract][Full Text] [Related]
5. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding. Dourado MR; Miwa KYM; Hamada GB; Paranaíba LMR; Sawazaki-Calone Í; Domingueti CB; Ervolino de Oliveira C; Furlan ECB; Longo BC; Almangush A; Salo T; Coletta RD Histopathology; 2020 May; 76(6):906-918. PubMed ID: 31984527 [TBL] [Abstract][Full Text] [Related]
6. Tumor-stroma ratio is a promising prognostic classifier in oropharyngeal cancer. Almangush A; Jouhi L; Haglund C; Hagström J; Mäkitie AA; Leivo I Hum Pathol; 2023 Jun; 136():16-24. PubMed ID: 37001738 [TBL] [Abstract][Full Text] [Related]
7. Tumor-stroma ratio is a crucial histological predictor of occult cervical lymph node metastasis and survival in early-stage (cT1/2N0) oral squamous cell carcinoma. Huang S; Cai H; Song F; Zhu Y; Hou C; Hou J Int J Oral Maxillofac Surg; 2022 Apr; 51(4):450-458. PubMed ID: 34412929 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological correlation of tumor-stroma ratio and inflammatory cell infiltrate with tumor grade and lymph node metastasis in squamous cell carcinoma of buccal mucosa and tongue in 41 cases with review of literature. Rani P; Gupta AJ; Mehrol C; Singh M; Khurana N; Passey JC J Cancer Res Ther; 2020; 16(3):445-451. PubMed ID: 32719249 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis. Almangush A; Alabi RO; Troiano G; Coletta RD; Salo T; Pirinen M; Mäkitie AA; Leivo I BMC Cancer; 2021 Apr; 21(1):480. PubMed ID: 33931044 [TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291 [TBL] [Abstract][Full Text] [Related]
11. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis. Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755 [TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness. Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the tumor-stroma ratio in gallbladder cancer. Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165 [TBL] [Abstract][Full Text] [Related]
14. Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade. Sakai T; Saito Y; Tateishi Y; Yamazawa S; Fukuoka O; Kobayashi K; Omura G; Akashi K; Yoshida M; Ando M; Ebihara Y; Yamasoba T Int J Clin Oncol; 2022 Dec; 27(12):1818-1827. PubMed ID: 36197545 [TBL] [Abstract][Full Text] [Related]
15. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. Wang K; Ma W; Wang J; Yu L; Zhang X; Wang Z; Tan B; Wang N; Bai B; Yang S; Liu H; Zhu S; Cheng Y J Thorac Oncol; 2012 Sep; 7(9):1457-61. PubMed ID: 22843085 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the tumor-stroma ratio in squamous cell lung cancer, a cohort study. Smit MA; Philipsen MW; Postmus PE; Putter H; Tollenaar RA; Cohen D; Mesker WE Cancer Treat Res Commun; 2020; 25():100247. PubMed ID: 33249210 [TBL] [Abstract][Full Text] [Related]
17. Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma. Kang J; Su M; Xu Q; Wang C; Yuan X; Han Z Oral Dis; 2023 Mar; 29(2):628-638. PubMed ID: 34455659 [TBL] [Abstract][Full Text] [Related]
18. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery. Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242 [TBL] [Abstract][Full Text] [Related]
19. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma. Mascitti M; Zhurakivska K; Togni L; Caponio VCA; Almangush A; Balercia P; Balercia A; Rubini C; Lo Muzio L; Santarelli A; Troiano G Histopathology; 2020 Nov; 77(5):810-822. PubMed ID: 32633006 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer. Vangangelt KMH; Green AR; Heemskerk IMF; Cohen D; van Pelt GW; Sobral-Leite M; Schmidt MK; Putter H; Rakha EA; Tollenaar RAEM; Mesker WE Int J Cancer; 2020 Apr; 146(8):2296-2304. PubMed ID: 31901133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]